Drug Shortage Report for DIASTAT
| Report ID | 201529 |
| Drug Identification Number | 02238162 |
| Brand name | DIASTAT |
| Common or Proper name | DIASTAT |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | DIAZEPAM |
| Strength(s) | 5MG |
| Dosage form(s) | GEL |
| Route of administration | RECTAL RECTAL |
| Packaging size | 2pk |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-07-28 |
| Estimated end date | 2024-01-19 |
| Actual end date | 2024-01-17 |
| Shortage status | Resolved |
| Updated date | 2024-01-18 |
| Company comments | delay in production |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2023-08-09 | English | Compare |